Read the full article on The Market Herald here.
- Medicinal cannabis company Little Green Pharma (LGP) has updated the market on its financial and operational activities over 2020's final quarterIn terms of finances, LGP's quarterly sales revenue hit $2.45 million, marking a 90 per cent upswing on the previous quarter
- All up, cash receipts for the period came in at $1.86 million, taking LGP's cash position for the quarter to just shy of $4.5 million
- The ASX-lister also continued its international market pursuits, completing its fist export to Germany and receiving a primary supplier role for a national French medicinal cannabis trial
Medicinal cannabis company Little Green Pharma (LGP) has updated...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LGP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $43.91M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.0¢ | $101.8K | 678.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16514 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 19768 | 3 |
View Market Depth
| Last trade - 12.12pm 21/10/2024 (20 minute delay) ? |
| LGP (ASX) Chart |